Canada markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6500-0.0290 (-4.27%)
At close: 04:00PM EDT
0.6310 -0.02 (-2.92%)
After hours: 06:44PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
5,600
5,600
7,592
6,493
4,065
Selling General and Administrative
3,231
3,231
2,945
2,634
2,444
Total Operating Expenses
8,831
8,831
10,537
9,127
6,509
Operating Income or Loss
-8,831
-8,831
-10,537
-9,127
-6,509
Total Other Income/Expenses Net
-
-
-
-
122.4
Income Before Tax
-8,402
-8,402
-10,516
-9,103
-6,305
Income from Continuing Operations
-8,402
-8,402
-10,516
-9,103
-6,305
Net Income
-8,402
-8,402
-10,516
-9,103
-6,305
Net Income available to common shareholders
-8,402
-8,402
-10,516
-9,103
-6,305
Basic EPS
-0.72
-0.61
-0.83
-0.73
-0.58
Diluted EPS
-0.72
-0.61
-0.83
-0.73
-0.58
Basic Average Shares
13,384
13,824
12,718
12,471
10,958
Diluted Average Shares
13,384
13,824
12,718
12,471
10,958